ACR Convergence 2026 has ended. This guide stays up as the record of who was there. See upcoming conferences
Novartis at ACR Convergence 2026
Nov 6–11, 2026 Orlando, FL ~15k attendees Website
Novartis brings 11 presentations to ACR Convergence 2026 in Orlando, and exhibits at Booth 3213. Its program centres on real-world evidence across spondyloarthritis, Sjögren's disease, vasculitis and polymyalgia rheumatica. It also covers lupus disease-activity endpoints, a guide to assessing Sjögren's disease, and NLRP3 inhibition in knee osteoarthritis.
| Organization | ACR Convergence 2026 Attendance |
|---|---|
Novartis East Hanover, NJ | |
A global medicines company developing and marketing prescription treatments. | Booth Exhibiting at Booth 3213 Sun, Nov 810:00am–5:00pmMon, Nov 910:00am–5:00pmTue, Nov 1010:00am–2:30pm Poster Sun Nov 8 10:30am–12:30pm Poster Sun Nov 8 10:30am–12:30pm Poster Mon Nov 9 10:30am–12:30pm Poster Mon Nov 9 10:30am–12:30pm Poster Mon Nov 9 10:30am–12:30pm Industry Mon Nov 9 5:30pm–7:30pm Turning Complexity Into Clinical Clarity: Practical Approaches for the Comprehensive Assessment of Sjögren's Disease Poster Tue Nov 10 10:30am–12:30pm Poster Tue Nov 10 10:30am–12:30pm Poster Tue Nov 10 10:30am–12:30pm Poster Tue Nov 10 10:30am–12:30pm |
Find decision makers at Novartis
Tell us what you sell and we’ll find the people at Novartis most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the American College of Rheumatology (ACR). Organization details are derived from the ACR’s published program and exhibitor floor plan, and each organization’s own website. Submit a correction